Tag: Vaccines
FDA Approves Pfizer, Moderna Shots for Those 5 Years and Younger
U.S. Centers for Disease Control and Prevention will vote on Saturday on whether to endorse the shots
Protection Against Omicron Strongest With Hybrid Immunity
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers strongest protection against omicron infection
FDA Panel Backs Pfizer, Moderna Shots for Children 5 Years and Younger
Panel's recommendations will now go to the FDA, which is expected to approve use of the vaccines this week
Exercise May Boost Immune Response to Flu Vaccine
However, acute exercise does not show benefit for generally inactive people
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
COVID-19 Vaccines Cut Mortality With Heart Failure
Those who are partially vaccinated and unvaccinated face same increased risk, while boosted and fully vaccinated adults fare best
FDA Advisors Back Moderna Shot for Older Children, Teens
Some panel members noted that the vaccine would likely help prevent serious illness but not be as good at blocking mild infections
Relative Risk for CVT Up After AZD1222 COVID-19 Vaccine
Relative rates of hospital contacts for coagulation disorder, cerebrovascular disease increased after AZD1222 vaccination
Vaccine Effectiveness Against SARS-CoV-2 Infection Wanes Over Time
However, for all ages, vaccine effectiveness against severe COVID-19 high overall at 90 percent five months or longer after two doses
FDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
Regulators have been concerned about reports of myocarditis seen mostly in young men receiving the Moderna vaccine
